Hydroxycarboxylic acid receptor 1

From WikiMD's WELLNESSPEDIA


Hydroxycarboxylic acid receptor 1 (HCAR1), also known as GPR81, is a G protein-coupled receptor (GPCR) that is encoded by the HCAR1 gene in humans. This receptor is primarily activated by lactate, a key metabolite in energy metabolism.

Function[edit]

HCAR1 is involved in the regulation of lipolysis in adipose tissue. When activated by lactate, HCAR1 inhibits the breakdown of fatty acids, thereby reducing the release of free fatty acids into the bloodstream. This mechanism is crucial for maintaining energy homeostasis and is particularly important during exercise when lactate levels are elevated.

Expression[edit]

HCAR1 is predominantly expressed in adipose tissue, but it is also found in other tissues such as the skeletal muscle and the brain. Its expression in the brain suggests a potential role in neurotransmission and neuroprotection.

Clinical Significance[edit]

The modulation of HCAR1 activity has been implicated in various metabolic disorders, including obesity and type 2 diabetes. As a result, HCAR1 is considered a potential target for the development of new therapeutic agents aimed at treating these conditions.

Research[edit]

Recent studies have explored the role of HCAR1 in cancer metabolism, as cancer cells often exhibit altered lactate production and utilization. Understanding the interaction between HCAR1 and lactate in the tumor microenvironment could lead to novel approaches in cancer therapy.

See Also[edit]

References[edit]


External Links[edit]

  • Hydroxycarboxylic acid receptor 1 on WikiMD

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.